[The clinical trial of a prototype of the new LAR-2 serially produced laser optometer].
Based on results of clinical trials of a new commercial laser optometer LAR-2, the authors suggest methodologic recommendations for ametropia diagnosis making use of this apparatus. The new device can adequately solve the major refraction problems: express diagnosis of ametropia, specification of the optimal vision correction in selection of eyeglasses, assessment of dynamic refraction. LAR-2 was found useful in the treatment of vision fatigue and amblyopia. A conclusion is made about diagnostic and clinical fitness of LAR-2 laser optometer; some minor shortcomings of the device are to be eliminated.
Rozenblium
Iu Z
IuZ
Avetisov
V E
VE
Maksudova
Z N
ZN
D000293:Adolescent; D000328:Adult; D000550:Amblyopia / Q000628:therapy; D001248:Asthenopia / Q000628:therapy; D002648:Child; D004867:Equipment Design; D006801:Humans; D007834:Lasers; D009907:Optometry / Q000295:instrumentation*; D012029:Refraction, Ocular; D012030:Refractive Errors / Q000175:diagnosis; D012426:Russia
Klinicheskaia aprobatsiia obraztsa novogo seriĭnogo lazernogo optometra LAR-2.